A detailed history of Royal Bank Of Canada transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 2,589 shares of OCUL stock, worth $17,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,589
Previous 24,092 89.25%
Holding current value
$17,708
Previous $107,000 78.5%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$3.85 - $10.93 $82,786 - $235,027
-21,503 Reduced 89.25%
2,589 $23,000
Q4 2023

Feb 14, 2024

SELL
$2.08 - $4.52 $303,014 - $658,473
-145,680 Reduced 85.81%
24,092 $107,000
Q3 2023

Nov 14, 2023

BUY
$3.14 - $5.04 $14,811 - $23,773
4,717 Added 2.86%
169,772 $533,000
Q2 2023

Aug 14, 2023

SELL
$4.6 - $7.64 $88,582 - $147,123
-19,257 Reduced 10.45%
165,055 $851,000
Q1 2023

May 15, 2023

BUY
$2.79 - $6.27 $488,088 - $1.1 Million
174,942 Added 1867.04%
184,312 $971,000
Q4 2022

Feb 14, 2023

BUY
$2.61 - $4.41 $10,784 - $18,222
4,132 Added 78.89%
9,370 $26,000
Q3 2022

Nov 14, 2022

BUY
$4.09 - $6.5 $17,603 - $27,976
4,304 Added 460.81%
5,238 $22,000
Q2 2022

Aug 15, 2022

SELL
$3.01 - $5.22 $203,503 - $352,918
-67,609 Reduced 98.64%
934 $4,000
Q1 2022

May 16, 2022

SELL
$4.83 - $7.35 $99,633 - $151,615
-20,628 Reduced 23.13%
68,543 $339,000
Q4 2021

Feb 14, 2022

BUY
$6.16 - $12.07 $48,627 - $95,280
7,894 Added 9.71%
89,171 $622,000
Q3 2021

Nov 15, 2021

BUY
$9.7 - $14.34 $31,835 - $47,063
3,282 Added 4.21%
81,277 $812,000
Q2 2021

Aug 16, 2021

BUY
$13.43 - $19.16 $1.05 Million - $1.49 Million
77,995 New
77,995 $1.11 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.